Menu
Recruiting NCT07369726

Effects of Mobilization and Caffeine After Cesarean

No phase Interventional Gastrointestinal Motility Postoperative Pain Psychological Well-Being

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: caffeine consumption, Decaffeinated coffee.
Who it may be relevant to
Registry conditions: Gastrointestinal Motility, Postoperative Pain, Psychological Well-Being. Basic parameters: 18 years — 35 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effect of Early Post-Cesarean Mobilization and Caffeine Consumption on Bowel Motility, Pain, and Psychological Well-being: A Randomized Controlled Trial

Overview

This study Maims to assess bowel motility, pain and psychological well-being in women in the post-cesarean period by mobilizing them early and encouraging them to consume coffee.

Detailed description

In the intervention group, the goal is to initiate bowel motility by mobilizing women early in the post-cesarean period. This increased bowel motility will facilitate gas expulsion, thus minimizing pain levels. Caffeine consumption will help keep pain levels at a minimum. By minimizing pain, women will experience positive psychological well-being.

Interventions

  • Dietary supplement caffeine consumption
    The women in the intervention group will be mobilised at the 4-hour mark. The intervention group will be given caffeinated Turkish coffee at 6-hour intervals.
  • Dietary supplement Decaffeinated coffee
    The women in the control group will be mobilised at the 6-hour mark. The control group will be given decaffeinated Turkish coffee at 6-hour intervals.

Primary outcome measures

  • Change in postoperative pain after caesarean section within 24 hours from baseline [Time frame: Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours]
  • Change in postoperative Bowel Motility after caesarean section within 24 hours from baseline [Time frame: Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours]
  • Change in postoperative Psychological Well-being after caesarean section within 24 hours from baseline [Time frame: Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours]

Eligibility criteria

Inclusion criteria

  • Being between 18 and 35 years of age,
  • Women who underwent cesarean delivery under spinal anesthesia,
  • Having a post-cesarean pain level of 4 or higher,
  • Being able to understand and write Turkish and communicate effectively with researchers.

Exclusion criteria

  • Women who underwent emergency cesarean delivery,
  • Those with pregnancy complications (preeclampsia, placenta previa, etc.),
  • Those with a history of chronic gastrointestinal disease (e.g., irritable bowel syndrome, Crohn's disease, ulcerative colitis),
  • Those with sensitivity or allergy to caffeine,
  • Those with a history of chronic pain syndrome or dependence on analgesics,
  • Regular coffee drinkers (≥2 cups per day),
  • Intraoperative complications such as bowel or bladder injury,

i) Those who cannot comply with the study protocol or complete the follow-up process.

Removal Criteria:

  • Participants are excluded from the study under the following conditions:
  • During surgery If complications occur (e.g., bladder or bowel injury, excessive bleeding),
  • Postoperative complications requiring admission to the intensive care unit (ICU) for the mother or newborn,
  • Development of severe postoperative nausea, vomiting, or intolerance to oral intake,
  • Inability to consume or refusal to consume coffee according to the study protocol,
  • Withdrawal of consent by the participant at any point during the study,
  • Failure to comply with surgical procedures or loss of follow-up,
  • Development of medical conditions during follow-up that may affect study results (e.g., acute infections, neurological disorders).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Supportive care

Study locations

Turkey (Türkiye) · 1 center
  • KTO Karatay University — Konya

Identifiers

NCT: NCT07369726 · AIBU-EBE-EK-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗